Aussie firm gets TGA approval for pancreatic cancer drug

Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...

March 18, 2014 | Tuesday | Regulatory
Pharmaxis gets grants for fibrotic research

Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...

July 8, 2013 | Monday | News
Regenerative Therapy for heart failure enters Ph III Trial

Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal ...

April 24, 2013 | Wednesday | News
Mesoblast to set up stem cell drug plant in Singapore

Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...

May 29, 2014 | Thursday | News
Sanford-Burnham, Daiichi form new alliance

Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...

May 26, 2014 | Monday | News
Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes

Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and saf...

March 21, 2013 | Thursday | News
Taiwan firm NCE to get priority review in China

Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into ...

March 21, 2013 | Thursday | News
Astrazeneca, China university in research deal

Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic instit...

December 19, 2012 | Wednesday | News
Phylogica extends collaboration with Janssen Biotech

Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...

January 31, 2013 | Thursday | News
AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug

Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...

November 29, 2013 | Friday | Regulatory
Regeneron acquires Sanofi eye care antibodies

Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...

May 6, 2013 | Monday | News
Teva, Xenon enter $335 mn deal for pain drug

Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...

December 12, 2012 | Wednesday | News
Linaclotide phase III trial initiated in China

Singapore: Ironwood Pharmaceuticals and AstraZeneca Pharmaceuticals have announced the initiation of a phase III clinica...

September 11, 2013 | Wednesday | News
Singapore firm, Stehlin Foundation collaborate on anti-cancer drug

Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement ...

October 15, 2013 | Tuesday | News
AseaCyte gets BioSpectrum award for drug discovery efforts

A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundatio...

March 15, 2013 | Friday | Influencers
Abraxane cancer trial shows positive results in Australia

Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic me...

October 29, 2012 | Monday | News
Astellas, Ambit terminate cancer drug deal

Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...

March 12, 2013 | Tuesday | News
Roche launches FLOW system

Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...

December 18, 2013 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls